General Information
Drug ID
DR00579
Drug Name
Dihydroergocristine
Synonyms
Nehydrin
Drug Type
Small molecular drug
Indication Alcohol use disorders [ICD11: 6C40] Approved [1]
Structure
3D MOL 2D MOL
Formula
C35H41N5O5
Canonical SMILES
CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
InChI
InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)
InChIKey
DEQITUUQPICUMR-UHFFFAOYSA-N
CAS Number
CAS 17479-19-5
Pharmaceutical Properties Molecular Weight 611.7 Topological Polar Surface Area 118
Heavy Atom Count 45 Rotatable Bond Count 5
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
XLogP
3.3
PubChem CID
3065
PubChem SID
104302426 , 11408320 , 126407528 , 135652679 , 179225314 , 221672740 , 242506325 , 29222211 , 479106 , 50125830 , 5635341 , 57321588 , 76464834 , 8141771 , 8151949 , 85209399 , 85256505 , 85788098
ChEBI ID
CHEBI:59912
TTD Drug ID
D09NNH
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Dihydroergocristine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. J Pharmacol Exp Ther. 2002 Oct;303(1):323-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.